Multivariate analysis of metabolic state vulnerabilities across diverse cancer contexts reveals synthetically lethal associations

Targeting the distinct metabolic needs of tumor cells has recently emerged as a promising strategy for cancer therapy. The heterogeneous, context-dependent nature of cancer cell metabolism, however, poses challenges to identifying effective therapeutic interventions. Here, we utilize various unsuper...

Full description

Saved in:
Bibliographic Details
Published inCell reports (Cambridge) Vol. 43; no. 10; p. 114775
Main Authors Abecunas, Cara, Kidd, Audrey D., Jiang, Ying, Zong, Hui, Fallahi-Sichani, Mohammad
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 22.10.2024
Elsevier
Subjects
Online AccessGet full text
ISSN2211-1247
2639-1856
2211-1247
DOI10.1016/j.celrep.2024.114775

Cover

Abstract Targeting the distinct metabolic needs of tumor cells has recently emerged as a promising strategy for cancer therapy. The heterogeneous, context-dependent nature of cancer cell metabolism, however, poses challenges to identifying effective therapeutic interventions. Here, we utilize various unsupervised and supervised multivariate modeling approaches to systematically pinpoint recurrent metabolic states within hundreds of cancer cell lines, elucidate their association with tumor lineage and growth environments, and uncover vulnerabilities linked to their metabolic states across diverse genetic and tissue contexts. We validate key findings via analysis of data from patient-derived tumors and pharmacological screens and by performing genetic and pharmacological experiments. Our analysis uncovers synthetically lethal associations between the tumor metabolic state (e.g., oxidative phosphorylation), driver mutations (e.g., loss of tumor suppressor PTEN), and actionable biological targets (e.g., mitochondrial electron transport chain). Investigating the mechanisms underlying these relationships can inform the development of more precise and context-specific, metabolism-targeted cancer therapies. [Display omitted] •Most metabolic pathway heterogeneities are cancer type specific; Oxphos variability is not•OxphosHigh and OxphosLow states show unique vulnerabilities independent of growth condition•PTEN loss increases OxphosHigh state’s dependency on mitochondrial electron transport chain•Oxphos inhibitors show higher potency in PTENNull glioma cells than in PTEN-expressing cells Abecunas et al. use multivariate modeling to explore recurrent metabolic states in cancer cells and uncover synthetically lethal interactions across diverse metabolic, oncogenic, and tissue contexts. They validate key findings via independent data analysis and new experiments. They find that PTEN loss predicts increased dependency on mitochondrial respiratory chain in OxphosHigh tumor cells.
AbstractList Targeting the distinct metabolic needs of tumor cells has recently emerged as a promising strategy for cancer therapy. The heterogeneous, context-dependent nature of cancer cell metabolism, however, poses challenges to identifying effective therapeutic interventions. Here, we utilize various unsupervised and supervised multivariate modeling approaches to systematically pinpoint recurrent metabolic states within hundreds of cancer cell lines, elucidate their association with tumor lineage and growth environments, and uncover vulnerabilities linked to their metabolic states across diverse genetic and tissue contexts. We validate key findings via analysis of data from patient-derived tumors and pharmacological screens and by performing genetic and pharmacological experiments. Our analysis uncovers synthetically lethal associations between the tumor metabolic state (e.g., oxidative phosphorylation), driver mutations (e.g., loss of tumor suppressor PTEN), and actionable biological targets (e.g., mitochondrial electron transport chain). Investigating the mechanisms underlying these relationships can inform the development of more precise and context-specific, metabolism-targeted cancer therapies.
Targeting the distinct metabolic needs of tumor cells has recently emerged as a promising strategy for cancer therapy. The heterogeneous, context-dependent nature of cancer cell metabolism, however, poses challenges to identifying effective therapeutic interventions. Here, we utilize various unsupervised and supervised multivariate modeling approaches to systematically pinpoint recurrent metabolic states within hundreds of cancer cell lines, elucidate their association with tumor lineage and growth environments, and uncover vulnerabilities linked to their metabolic states across diverse genetic and tissue contexts. We validate key findings via analysis of data from patient-derived tumors and pharmacological screens and by performing genetic and pharmacological experiments. Our analysis uncovers synthetically lethal associations between the tumor metabolic state (e.g., oxidative phosphorylation), driver mutations (e.g., loss of tumor suppressor PTEN), and actionable biological targets (e.g., mitochondrial electron transport chain). Investigating the mechanisms underlying these relationships can inform the development of more precise and context-specific, metabolism-targeted cancer therapies. Abecunas et al. use multivariate modeling to explore recurrent metabolic states in cancer cells and uncover synthetically lethal interactions across diverse metabolic, oncogenic, and tissue contexts. They validate key findings via independent data analysis and new experiments. They find that PTEN loss predicts increased dependency on mitochondrial respiratory chain in OxphosHigh tumor cells.
Targeting the distinct metabolic needs of tumor cells has recently emerged as a promising strategy for cancer therapy. The heterogeneous, context-dependent nature of cancer cell metabolism, however, poses challenges to identifying effective therapeutic interventions. Here, we utilize various unsupervised and supervised multivariate modeling approaches to systematically pinpoint recurrent metabolic states within hundreds of cancer cell lines, elucidate their association with tumor lineage and growth environments, and uncover vulnerabilities linked to their metabolic states across diverse genetic and tissue contexts. We validate key findings via analysis of data from patient-derived tumors and pharmacological screens and by performing genetic and pharmacological experiments. Our analysis uncovers synthetically lethal associations between the tumor metabolic state (e.g., oxidative phosphorylation), driver mutations (e.g., loss of tumor suppressor PTEN), and actionable biological targets (e.g., mitochondrial electron transport chain). Investigating the mechanisms underlying these relationships can inform the development of more precise and context-specific, metabolism-targeted cancer therapies.Targeting the distinct metabolic needs of tumor cells has recently emerged as a promising strategy for cancer therapy. The heterogeneous, context-dependent nature of cancer cell metabolism, however, poses challenges to identifying effective therapeutic interventions. Here, we utilize various unsupervised and supervised multivariate modeling approaches to systematically pinpoint recurrent metabolic states within hundreds of cancer cell lines, elucidate their association with tumor lineage and growth environments, and uncover vulnerabilities linked to their metabolic states across diverse genetic and tissue contexts. We validate key findings via analysis of data from patient-derived tumors and pharmacological screens and by performing genetic and pharmacological experiments. Our analysis uncovers synthetically lethal associations between the tumor metabolic state (e.g., oxidative phosphorylation), driver mutations (e.g., loss of tumor suppressor PTEN), and actionable biological targets (e.g., mitochondrial electron transport chain). Investigating the mechanisms underlying these relationships can inform the development of more precise and context-specific, metabolism-targeted cancer therapies.
Targeting the distinct metabolic needs of tumor cells has recently emerged as a promising strategy for cancer therapy. The heterogeneous, context-dependent nature of cancer cell metabolism, however, poses challenges to identifying effective therapeutic interventions. Here, we utilize various unsupervised and supervised multivariate modeling approaches to systematically pinpoint recurrent metabolic states within hundreds of cancer cell lines, elucidate their association with tumor lineage and growth environments, and uncover vulnerabilities linked to their metabolic states across diverse genetic and tissue contexts. We validate key findings via analysis of data from patient-derived tumors and pharmacological screens and by performing genetic and pharmacological experiments. Our analysis uncovers synthetically lethal associations between the tumor metabolic state (e.g., oxidative phosphorylation), driver mutations (e.g., loss of tumor suppressor PTEN), and actionable biological targets (e.g., mitochondrial electron transport chain). Investigating the mechanisms underlying these relationships can inform the development of more precise and context-specific, metabolism-targeted cancer therapies. [Display omitted] •Most metabolic pathway heterogeneities are cancer type specific; Oxphos variability is not•OxphosHigh and OxphosLow states show unique vulnerabilities independent of growth condition•PTEN loss increases OxphosHigh state’s dependency on mitochondrial electron transport chain•Oxphos inhibitors show higher potency in PTENNull glioma cells than in PTEN-expressing cells Abecunas et al. use multivariate modeling to explore recurrent metabolic states in cancer cells and uncover synthetically lethal interactions across diverse metabolic, oncogenic, and tissue contexts. They validate key findings via independent data analysis and new experiments. They find that PTEN loss predicts increased dependency on mitochondrial respiratory chain in OxphosHigh tumor cells.
ArticleNumber 114775
Author Fallahi-Sichani, Mohammad
Abecunas, Cara
Kidd, Audrey D.
Jiang, Ying
Zong, Hui
AuthorAffiliation 4 UVA Comprehensive Cancer Center, University of Virginia, Charlottesville, VA 22908, USA
2 Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, USA
5 Present address: Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA
6 Lead contact
3 Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA 22908, USA
1 Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908, USA
AuthorAffiliation_xml – name: 1 Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908, USA
– name: 5 Present address: Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA
– name: 4 UVA Comprehensive Cancer Center, University of Virginia, Charlottesville, VA 22908, USA
– name: 6 Lead contact
– name: 3 Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA 22908, USA
– name: 2 Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, USA
Author_xml – sequence: 1
  givenname: Cara
  surname: Abecunas
  fullname: Abecunas, Cara
  organization: Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908, USA
– sequence: 2
  givenname: Audrey D.
  surname: Kidd
  fullname: Kidd, Audrey D.
  organization: Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908, USA
– sequence: 3
  givenname: Ying
  surname: Jiang
  fullname: Jiang, Ying
  organization: Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA 22908, USA
– sequence: 4
  givenname: Hui
  surname: Zong
  fullname: Zong, Hui
  organization: Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA 22908, USA
– sequence: 5
  givenname: Mohammad
  orcidid: 0000-0003-0917-3525
  surname: Fallahi-Sichani
  fullname: Fallahi-Sichani, Mohammad
  email: fallahi@virginia.edu
  organization: Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39305483$$D View this record in MEDLINE/PubMed
BookMark eNqNkU9v1DAQxSNUREvpN0AoRy67eGJ7nVxAqOJPpSIucLYmzqTrlddebG9gj3xzvE2p2gvCF1v2m_dm_HtenfjgqapeAlsCg9WbzdKQi7RbNqwRSwChlHxSnTUNwAIaoU4enE-ri5Q2rKwVA-jEs-qUd5xJ0fKz6veXvct2wmgxU40e3SHZVIex3lLGPjhr6pSPb9PeeYrYW2ezpVSjiSGlerATxUS1QW8o1ib4TL9yqiNNhC7V6eDzmrI16NyhdpTX6GpMKZiSaINPL6qnYxHSxd1-Xn3_-OHb5efF9ddPV5fvrxdGqC4vOICCVjXAuWkQUHZMlBkkddwgDaMyA_UIyqw63hoYWSu7oWetEC3jI0h-Xl3NvkPAjd5Fu8V40AGtvr0I8UZjLH060mboJJFkUqpBtCCwRd6ZnquWgWJMFS85e-39Dg8_y2j3hsD0kZDe6JmQPhLSM6FS926u2-37LQ2GfI7oHjXz-MXbtb4JU6mXACvOisPrO4cYfuwpZb21qSQ59BT2SXNgSrWyaIv01cOw-5S_8ItAzIJbkpHG_x3i7VxGhdZkKepkLBX6g41kcvlO-2-DP9MR3jo
Cites_doi 10.1186/s13059-021-02540-7
10.1016/0169-7439(93)E0075-F
10.1038/nchembio.1986
10.1093/nar/gkad986
10.1158/2159-8290.CD-20-0844
10.7171/jbt.18-2902-002
10.1016/j.trecan.2019.05.004
10.1038/s42255-021-00388-6
10.1158/0008-5472.CAN-22-0883
10.1093/nar/gkv1070
10.1016/j.celrep.2021.108750
10.1016/j.celrep.2021.109024
10.1371/journal.pone.0123721
10.1016/j.cell.2013.08.032
10.1186/s12915-019-0654-4
10.1038/s41586-019-0993-x
10.1038/s41587-020-0546-8
10.1016/j.celrep.2022.111818
10.1158/1078-0432.CCR-19-0032
10.1158/2159-8290.CD-12-0095
10.1038/s43018-020-00159-4
10.1038/s41591-022-02103-8
10.1038/s41591-019-0404-8
10.1038/s41467-021-26213-y
10.1038/s41586-019-1103-9
10.1038/s41586-023-05793-3
10.1038/s41467-021-27329-x
10.1038/s41467-018-04033-x
10.1038/s41467-021-22236-7
10.1186/s12859-021-04344-9
10.1016/j.bbcan.2018.05.002
10.1016/j.tcb.2021.05.003
10.1126/science.1236062
10.1158/2159-8290.CD-16-1034
10.1038/s41574-023-00833-4
10.1038/s41568-019-0226-5
10.1038/s41467-020-20294-x
10.1158/0008-5472.CAN-17-0165
10.1038/s41591-018-0052-4
10.1093/neuonc/now062
10.1126/science.aaf5171
10.1038/nature11003
10.1038/s42255-023-00817-8
10.1093/nar/gkw377
10.1002/gene.10036
10.1073/pnas.1921815117
10.15252/msb.202211033
10.1038/nprot.2011.319
10.1038/s41573-021-00339-6
10.1038/s41540-023-00305-5
10.1038/s41586-019-1186-3
10.1016/j.ccell.2022.10.009
10.1038/s41467-019-11738-0
10.1038/s41467-023-38360-5
10.1038/nchembio.94
10.1371/journal.pcbi.1008942
10.1186/s40170-021-00272-7
10.1038/ng.2764
10.1038/s41586-019-1775-1
10.1016/j.cell.2023.01.038
10.1038/s41586-023-06073-w
10.1038/s41392-022-01243-0
10.1038/nature22359
10.1016/j.cell.2011.06.014
10.1016/0076-6879(79)55061-7
10.1038/nbt.4314
10.1016/j.chom.2018.07.009
10.1038/s41588-020-00726-6
10.15252/msb.202211006
10.1038/s41416-023-02394-9
10.1038/s41467-023-43917-5
10.1016/j.celrep.2018.03.032
10.1038/s41467-020-18376-x
ContentType Journal Article
Copyright 2024 The Author(s)
Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2024 The Author(s)
– notice: Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.
DBID 6I.
AAFTH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ADTOC
UNPAY
DOA
DOI 10.1016/j.celrep.2024.114775
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Unpaywall for CDI: Periodical Content
Unpaywall
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE


MEDLINE - Academic

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2211-1247
EndPage 114775
ExternalDocumentID oai_doaj_org_article_cd95ee50557d4814a8a39cb378017007
10.1016/j.celrep.2024.114775
PMC11511630
39305483
10_1016_j_celrep_2024_114775
S2211124724011264
Genre Journal Article
GrantInformation_xml – fundername: NIGMS NIH HHS
  grantid: R35 GM133404
– fundername: NCI NIH HHS
  grantid: U54 CA274499
– fundername: NCI NIH HHS
  grantid: R01 CA249229
– fundername: NCI NIH HHS
  grantid: P30 CA044579
– fundername: NINDS NIH HHS
  grantid: R21 NS125479
– fundername: NIGMS NIH HHS
  grantid: T32 GM145443
GroupedDBID 0R~
4.4
457
53G
5VS
6I.
AAEDT
AAEDW
AAFTH
AAIKJ
AAKRW
AALRI
AAMRU
AAXUO
AAYWO
ABMAC
ACGFO
ACGFS
ADBBV
ADEZE
ADVLN
AENEX
AEXQZ
AFTJW
AGHFR
AITUG
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
APXCP
BAWUL
BCNDV
DIK
EBS
EJD
FCP
FDB
FRP
GROUPED_DOAJ
GX1
IXB
KQ8
M41
M48
O-L
O9-
OK1
ROL
SSZ
AAYXX
ACVFH
ADCNI
AEUPX
AFPUW
AIGII
AKBMS
AKYEP
CITATION
HZ~
IPNFZ
RIG
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ADTOC
UNPAY
ID FETCH-LOGICAL-c479t-31171872133c2a1a59040545e93caedf7cdeba17c6938c1f0859db0844803f153
IEDL.DBID DOA
ISSN 2211-1247
2639-1856
IngestDate Wed Aug 27 01:21:24 EDT 2025
Tue Aug 19 09:30:31 EDT 2025
Tue Sep 30 17:07:37 EDT 2025
Fri Jul 11 03:50:50 EDT 2025
Mon Jul 21 06:06:16 EDT 2025
Wed Oct 01 08:28:22 EDT 2025
Sat May 24 17:06:17 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords multivariate modeling
cancer metabolism
cancer therapies
mitochondrial electron transport chain
metabolic state vulnerabilities
CP: Metabolism
CP: Cancer
synthetic lethality
PTEN
glioma
oxidative phosphorylation
Language English
License This is an open access article under the CC BY-NC-ND license.
Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c479t-31171872133c2a1a59040545e93caedf7cdeba17c6938c1f0859db0844803f153
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
AUTHOR CONTRIBUTIONS
C.A. and M.F.-S. conceived and designed the study. C.A. performed the computational modeling work. A.D.K. and Y.J. performed the experiments. A.D.K. analyzed the experimental data. C.A., A.D.K., Y.J., H.Z., and M.F.-S. wrote and edited the manuscript. M.F.-S. supervised the work.
ORCID 0000-0003-0917-3525
OpenAccessLink https://doaj.org/article/cd95ee50557d4814a8a39cb378017007
PMID 39305483
PQID 3107785163
PQPubID 23479
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_cd95ee50557d4814a8a39cb378017007
unpaywall_primary_10_1016_j_celrep_2024_114775
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11511630
proquest_miscellaneous_3107785163
pubmed_primary_39305483
crossref_primary_10_1016_j_celrep_2024_114775
elsevier_sciencedirect_doi_10_1016_j_celrep_2024_114775
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-10-22
PublicationDateYYYYMMDD 2024-10-22
PublicationDate_xml – month: 10
  year: 2024
  text: 2024-10-22
  day: 22
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Cell reports (Cambridge)
PublicationTitleAlternate Cell Rep
PublicationYear 2024
Publisher Elsevier Inc
Elsevier
Publisher_xml – name: Elsevier Inc
– name: Elsevier
References Fendt, Frezza, Erez (bib4) 2020; 10
Bi, Chowdhry, Wu, Zhang, Masui, Mischel (bib64) 2020; 20
Yang, Griffin, Qiang, Ren (bib19) 2022; 7
Ackermann, Tardito (bib32) 2019; 5
Mayers, Vander Heiden (bib54) 2017; 77
Jonsson, Lin, Young, DiStefano, Hyman, Li, Berger, Zehir, Ladanyi, Solit (bib44) 2019; 25
Yen, Travins, Wang, David, Artin, Straley, Padyana, Gross, DeLaBarre, Tobin (bib7) 2017; 7
Sondka, Dhir, Carvalho-Silva, Jupe, Ahmed, McLaren, Starkey, Ward, Wilding (bib34) 2024; 52
Ledur, Liu, He, Harris, Minussi, Zhou, Shaffrey, Asthagiri, Lopes, Schiff (bib50) 2016; 18
Sun, Wang, Zhou, Chen, Wang, Huang, Gao, Wang, Shu, Lu (bib67) 2023; 14
Du, Su, Qian, Yuan, Miao, Lee, Ng, Wijker, Ribas, Levine (bib53) 2020; 11
Xia, Wishart (bib30) 2011; 6
Stirling, Swain-Bowden, Lucas, Carpenter, Cimini, Goodman (bib70) 2021; 22
Nwosu, Ward, Sajjakulnukit, Poudel, Ragulan, Kasperek, Radyk, Sutton, Menjivar, Andren (bib9) 2023; 618
Joly, Chew, Graham (bib13) 2021; 17
Goldman, Craft, Hastie, Repečka, McDade, Kamath, Banerjee, Luo, Rogers, Brooks (bib28) 2020; 38
Liu, Sage, Miller, Verhaak, Hippenmeyer, Vogel, Foreman, Bronson, Nishiyama, Luo, Zong (bib71) 2011; 146
Sessions, Kim, Kashatus, Churchill, Park, Mayo, Sesaki, Kashatus (bib22) 2022; 41
Barretina, Caponigro, Stransky, Venkatesan, Margolin, Kim, Wilson, Lehár, Kryukov, Sonkin (bib23) 2012; 483
Lesche, Groszer, Gao, Wang, Messing, Sun, Liu, Wu (bib72) 2002; 32
Bayona-Bafaluy, Montoya, Ruiz-Pesini (bib33) 2021; 31
Bi, Wu, Zhang, Mischel (bib3) 2018; 1870
Leeuwenburgh, Urzúa-Traslaviña, Bhattacharya, Walvoort, Jalving, de Jong, Fehrmann (bib18) 2021; 9
Dempster, Boyle, Vazquez, Root, Boehm, Hahn, Tsherniak, McFarland (bib35) 2021; 22
Wold (bib73) 1994; 23
Mayers, Torrence, Danai, Papagiannakopoulos, Davidson, Bauer, Lau, Ji, Dixit, Hosios (bib55) 2016; 353
Molina, Sun, Protopopova, Gera, Bandi, Bristow, McAfoos, Morlacchi, Ackroyd, Agip (bib46) 2018; 24
Foretz, Guigas, Viollet (bib51) 2023; 19
Cogliati, Frezza, Soriano, Varanita, Quintana-Cabrera, Corrado, Cipolat, Costa, Casarin, Gomes (bib57) 2013; 155
Weinstein, Collisson, Mills, Shaw, Ozenberger, Ellrott, Shmulevich, Sander, Stuart (bib27) 2013; 45
Machado, Heather, Harris, Higgins (bib61) 2023; 129
Kondo, Ratcliffe, Hooper, Ellis, MacRae, Hennequart, Dunsby, Anderson, Sahai (bib5) 2021; 34
Shi, Lim, Liang, Iyer, Wang, Wang, Xie, Sun, Chen, Tabar (bib45) 2019; 567
Garofano, Migliozzi, Oh, D’Angelo, Najac, Ko, Frangaj, Caruso, Yu, Yuan (bib62) 2021; 2
Ghandi, Huang, Jané-Valbuena, Kryukov, Lo, McDonald, Barretina, Gelfand, Bielski, Li (bib12) 2019; 569
Kanehisa, Sato, Kawashima, Furumichi, Tanabe (bib25) 2016; 44
Ulanovskaya, Janjic, Suzuki, Sabharwal, Schumacker, Kron, Kozmin (bib43) 2008; 4
Becht, McInnes, Healy, Dutertre, Kwok, Ng, Ginhoux, Newell (bib24) 2018; 37
Sesen, Dahan, Scotland, Saland, Dang, Lemarié, Tyler, Brem, Toulas, Cohen-Jonathan Moyal (bib47) 2015; 10
Stine, Schug, Salvino, Dang (bib2) 2022; 21
Finley (bib1) 2023; 186
Naguib, Mathew, Reczek, Watrud, Ambrico, Herzka, Salas, Lee, El-Amine, Zheng (bib59) 2018; 23
Barthel, Johnson, Varn, Moskalik, Tanner, Kocakavuk, Anderson, Abiola, Aldape, Alfaro (bib48) 2019; 576
Kinker, Greenwald, Tal, Orlova, Cuoco, McFarland, Warren, Rodman, Roth, Bender (bib31) 2020; 52
Hu, Allam, Cai, Henderson, Yueh, Garipcan, Ievlev, Afkarian, Beyaz, Coskun (bib65) 2023; 14
Bairoch (bib68) 2018; 29
Xiao, Dai, Locasale (bib29) 2019; 10
Rees, Seashore-Ludlow, Cheah, Adams, Price, Gill, Javaid, Coletti, Jones, Bodycombe (bib41) 2016; 12
Shorthouse, Bradley, Critchlow, Bendtsen, Hall (bib16) 2022; 18
Behan, Iorio, Picco, Gonçalves, Beaver, Migliardi, Santos, Rao, Sassi, Pinnelli (bib36) 2019; 568
Sighel, Notarangelo, Aibara, Re, Ricci, Guida, Soldano, Adami, Ambrosini, Broso (bib63) 2021; 35
Gwynne, Suk, Custers, Mikolajewicz, Chan, Zador, Chafe, Zhai, Escudero, Zhang (bib10) 2022; 40
Yap, Daver, Mahendra, Zhang, Kamiya-Matsuoka, Meric-Bernstam, Kantarjian, Ravandi, Collins, Francesco (bib60) 2023; 29
Selva, van de Sandt, Lemke, Lee, Shoffner, Chua, Davis, Nguyen, Rowntree, Hensen (bib38) 2021; 12
Cherkaoui, Durot, Bradley, Critchlow, Dubuis, Masiero, Wegmann, Snijder, Othman, Bendtsen, Zamboni (bib15) 2022; 18
Cerami, Gao, Dogrusoz, Gross, Sumer, Aksoy, Jacobsen, Byrne, Heuer, Larsson (bib74) 2012; 2
Li, Ning, Ghandi, Kryukov, Gopal, Deik, Souza, Pierce, Keskula, Hernandez (bib11) 2019; 25
Pemovska, Bigenzahn, Srndic, Lercher, Bergthaler, César-Razquin, Kartnig, Kornauth, Valent, Staber, Superti-Furga (bib17) 2021; 12
Anderson, Wardell, Cakir, Yip, Ahn, Ali, Yllanes, Chao, McDonnell, Wood (bib58) 2018; 9
Warren, Chen, Jones, Shibue, Hahn, Boehm, Vazquez, Tsherniak, McFarland (bib26) 2021; 12
Zhang, Cao, Dong, Lin (bib39) 2020; 117
Han, Bushong, Segawa, Tiard, Wong, Brady, Momcilovic, Wolf, Zhang, Petcherski (bib56) 2023; 615
Abecunas, Whitehead, Ziemke, Baumann, Frankowski-McGregor, Sebolt-Leopold, Fallahi-Sichani (bib75) 2023; 83
Campit, Bhowmick, Lu, Saoji, Jin, Robida, Chandrasekaran (bib21) 2023
Gunn, Yu, Karim, Brannan, Herbert, Wec, Halfmann, Fusco, Schendel, Gangavarapu (bib37) 2018; 24
Kuleshov, Jones, Rouillard, Fernandez, Duan, Wang, Koplev, Jenkins, Jagodnik, Lachmann (bib69) 2016; 44
Kim, Hu, Cai, Li, Choi, Faubert, Bezwada, Rodriguez-Canales, Villalobos, Lin (bib8) 2017; 546
Ruiz-Moreno, Salas, Samuelsson, Brandner, Kranendonk, Nilsson, Stunnenberg (bib49) 2022
Maan, Baghel, Dhariwal, Sharma, Bakhshi, Rana (bib66) 2023; 9
Mendiratta, Ke, Aziz, Liarakos, Tong, Stites (bib40) 2021; 12
Lagziel, Lee, Shlomi (bib14) 2019; 17
Linnett, Beechey (bib42) 1979
Rohle, Popovici-Muller, Palaskas, Turcan, Grommes, Campos, Tsoi, Clark, Oldrini, Komisopoulou (bib6) 2013; 340
Benedetti, Liu, Tang, Kuo, Buyukozkan, Park, Park, Correa, Hakimi, Intlekofer (bib20) 2023; 5
Mahendralingam, Kim, McCloskey, Aliar, Casey, Tharmapalan, Pellacani, Ignatchenko, Garcia-Valero, Palomero (bib52) 2021; 3
Shi (10.1016/j.celrep.2024.114775_bib45) 2019; 567
Molina (10.1016/j.celrep.2024.114775_bib46) 2018; 24
Mendiratta (10.1016/j.celrep.2024.114775_bib40) 2021; 12
Lagziel (10.1016/j.celrep.2024.114775_bib14) 2019; 17
Cerami (10.1016/j.celrep.2024.114775_bib74) 2012; 2
Ghandi (10.1016/j.celrep.2024.114775_bib12) 2019; 569
Ledur (10.1016/j.celrep.2024.114775_bib50) 2016; 18
Fendt (10.1016/j.celrep.2024.114775_bib4) 2020; 10
Warren (10.1016/j.celrep.2024.114775_bib26) 2021; 12
Barthel (10.1016/j.celrep.2024.114775_bib48) 2019; 576
Foretz (10.1016/j.celrep.2024.114775_bib51) 2023; 19
Naguib (10.1016/j.celrep.2024.114775_bib59) 2018; 23
Ackermann (10.1016/j.celrep.2024.114775_bib32) 2019; 5
Maan (10.1016/j.celrep.2024.114775_bib66) 2023; 9
Sondka (10.1016/j.celrep.2024.114775_bib34) 2024; 52
Joly (10.1016/j.celrep.2024.114775_bib13) 2021; 17
Barretina (10.1016/j.celrep.2024.114775_bib23) 2012; 483
Sesen (10.1016/j.celrep.2024.114775_bib47) 2015; 10
Mayers (10.1016/j.celrep.2024.114775_bib54) 2017; 77
Lesche (10.1016/j.celrep.2024.114775_bib72) 2002; 32
Becht (10.1016/j.celrep.2024.114775_bib24) 2018; 37
Garofano (10.1016/j.celrep.2024.114775_bib62) 2021; 2
Pemovska (10.1016/j.celrep.2024.114775_bib17) 2021; 12
Rees (10.1016/j.celrep.2024.114775_bib41) 2016; 12
Gunn (10.1016/j.celrep.2024.114775_bib37) 2018; 24
Sighel (10.1016/j.celrep.2024.114775_bib63) 2021; 35
Weinstein (10.1016/j.celrep.2024.114775_bib27) 2013; 45
Kanehisa (10.1016/j.celrep.2024.114775_bib25) 2016; 44
Mahendralingam (10.1016/j.celrep.2024.114775_bib52) 2021; 3
Rohle (10.1016/j.celrep.2024.114775_bib6) 2013; 340
Abecunas (10.1016/j.celrep.2024.114775_bib75) 2023; 83
Xiao (10.1016/j.celrep.2024.114775_bib29) 2019; 10
Leeuwenburgh (10.1016/j.celrep.2024.114775_bib18) 2021; 9
Campit (10.1016/j.celrep.2024.114775_bib21) 2023
Ulanovskaya (10.1016/j.celrep.2024.114775_bib43) 2008; 4
Selva (10.1016/j.celrep.2024.114775_bib38) 2021; 12
Du (10.1016/j.celrep.2024.114775_bib53) 2020; 11
Cherkaoui (10.1016/j.celrep.2024.114775_bib15) 2022; 18
Zhang (10.1016/j.celrep.2024.114775_bib39) 2020; 117
Anderson (10.1016/j.celrep.2024.114775_bib58) 2018; 9
Dempster (10.1016/j.celrep.2024.114775_bib35) 2021; 22
Machado (10.1016/j.celrep.2024.114775_bib61) 2023; 129
Ruiz-Moreno (10.1016/j.celrep.2024.114775_bib49) 2022
Sessions (10.1016/j.celrep.2024.114775_bib22) 2022; 41
Wold (10.1016/j.celrep.2024.114775_bib73) 1994; 23
Shorthouse (10.1016/j.celrep.2024.114775_bib16) 2022; 18
Kinker (10.1016/j.celrep.2024.114775_bib31) 2020; 52
Yap (10.1016/j.celrep.2024.114775_bib60) 2023; 29
Jonsson (10.1016/j.celrep.2024.114775_bib44) 2019; 25
Cogliati (10.1016/j.celrep.2024.114775_bib57) 2013; 155
Kondo (10.1016/j.celrep.2024.114775_bib5) 2021; 34
Nwosu (10.1016/j.celrep.2024.114775_bib9) 2023; 618
Bi (10.1016/j.celrep.2024.114775_bib3) 2018; 1870
Kim (10.1016/j.celrep.2024.114775_bib8) 2017; 546
Kuleshov (10.1016/j.celrep.2024.114775_bib69) 2016; 44
Linnett (10.1016/j.celrep.2024.114775_bib42) 1979
Goldman (10.1016/j.celrep.2024.114775_bib28) 2020; 38
Yang (10.1016/j.celrep.2024.114775_bib19) 2022; 7
Han (10.1016/j.celrep.2024.114775_bib56) 2023; 615
Gwynne (10.1016/j.celrep.2024.114775_bib10) 2022; 40
Stine (10.1016/j.celrep.2024.114775_bib2) 2022; 21
Li (10.1016/j.celrep.2024.114775_bib11) 2019; 25
Benedetti (10.1016/j.celrep.2024.114775_bib20) 2023; 5
Sun (10.1016/j.celrep.2024.114775_bib67) 2023; 14
Behan (10.1016/j.celrep.2024.114775_bib36) 2019; 568
Yen (10.1016/j.celrep.2024.114775_bib7) 2017; 7
Mayers (10.1016/j.celrep.2024.114775_bib55) 2016; 353
Liu (10.1016/j.celrep.2024.114775_bib71) 2011; 146
Finley (10.1016/j.celrep.2024.114775_bib1) 2023; 186
Stirling (10.1016/j.celrep.2024.114775_bib70) 2021; 22
Xia (10.1016/j.celrep.2024.114775_bib30) 2011; 6
Bayona-Bafaluy (10.1016/j.celrep.2024.114775_bib33) 2021; 31
Hu (10.1016/j.celrep.2024.114775_bib65) 2023; 14
Bairoch (10.1016/j.celrep.2024.114775_bib68) 2018; 29
Bi (10.1016/j.celrep.2024.114775_bib64) 2020; 20
38076921 - bioRxiv. 2024 Jul 10:2023.11.28.569098. doi: 10.1101/2023.11.28.569098
References_xml – volume: 353
  start-page: 1161
  year: 2016
  end-page: 1165
  ident: bib55
  article-title: Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers
  publication-title: Science
– volume: 20
  start-page: 57
  year: 2020
  end-page: 70
  ident: bib64
  article-title: Altered cellular metabolism in gliomas - an emerging landscape of actionable co-dependency targets
  publication-title: Nat. Rev. Cancer
– volume: 10
  year: 2015
  ident: bib47
  article-title: Metformin inhibits growth of human glioblastoma cells and enhances therapeutic response
  publication-title: PLoS One
– volume: 38
  start-page: 675
  year: 2020
  end-page: 678
  ident: bib28
  article-title: Visualizing and interpreting cancer genomics data via the Xena platform
  publication-title: Nat. Biotechnol.
– year: 2022
  ident: bib49
  article-title: Harmonized single-cell landscape, intercellular crosstalk and tumor architecture of glioblastoma
  publication-title: bioRxiv
– volume: 12
  start-page: 5961
  year: 2021
  ident: bib40
  article-title: Cancer gene mutation frequencies for the U.S. population
  publication-title: Nat. Commun.
– volume: 4
  start-page: 418
  year: 2008
  end-page: 424
  ident: bib43
  article-title: Synthesis enables identification of the cellular target of leucascandrolide A and neopeltolide
  publication-title: Nat. Chem. Biol.
– volume: 1870
  start-page: 76
  year: 2018
  end-page: 87
  ident: bib3
  article-title: Targeting cancer’s metabolic co-dependencies: A landscape shaped by genotype and tissue context
  publication-title: Biochim. Biophys. Acta Rev. Canc
– volume: 23
  start-page: 149
  year: 1994
  end-page: 161
  ident: bib73
  article-title: Exponentially weighted moving principal components analysis and projections to latent structures
  publication-title: Chemometr. Intell. Lab. Syst.
– volume: 18
  start-page: 1413
  year: 2016
  end-page: 1424
  ident: bib50
  article-title: Culture conditions tailored to the cell of origin are critical for maintaining native properties and tumorigenicity of glioma cells
  publication-title: Neuro Oncol.
– volume: 44
  start-page: W90
  year: 2016
  end-page: W97
  ident: bib69
  article-title: Enrichr: a comprehensive gene set enrichment analysis web server 2016 update
  publication-title: Nucleic Acids Res.
– volume: 22
  start-page: 433
  year: 2021
  ident: bib70
  article-title: CellProfiler 4: improvements in speed, utility and usability
  publication-title: BMC Bioinf.
– volume: 576
  start-page: 112
  year: 2019
  end-page: 120
  ident: bib48
  article-title: Longitudinal molecular trajectories of diffuse glioma in adults
  publication-title: Nature
– year: 2023
  ident: bib21
  article-title: Data-Driven Screening to Infer Metabolic Modulators of the Cancer Epigenome
  publication-title: bioRxiv
– volume: 45
  start-page: 1113
  year: 2013
  end-page: 1120
  ident: bib27
  article-title: The Cancer Genome Atlas Pan-Cancer analysis project
  publication-title: Nat. Genet.
– volume: 11
  start-page: 4830
  year: 2020
  ident: bib53
  article-title: Raman-guided subcellular pharmaco-metabolomics for metastatic melanoma cells
  publication-title: Nat. Commun.
– volume: 29
  start-page: 115
  year: 2023
  end-page: 126
  ident: bib60
  article-title: Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials
  publication-title: Nat. Med.
– volume: 24
  start-page: 221
  year: 2018
  end-page: 233.e5
  ident: bib37
  article-title: A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus
  publication-title: Cell Host Microbe
– volume: 14
  start-page: 8260
  year: 2023
  ident: bib65
  article-title: Single-cell spatial metabolomics with cell-type specific protein profiling for tissue systems biology
  publication-title: Nat. Commun.
– volume: 32
  start-page: 148
  year: 2002
  end-page: 149
  ident: bib72
  article-title: Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene
  publication-title: Genesis
– volume: 9
  start-page: 1677
  year: 2018
  ident: bib58
  article-title: Dysregulation of mitochondrial dynamics proteins are a targetable feature of human tumors
  publication-title: Nat. Commun.
– volume: 340
  start-page: 626
  year: 2013
  end-page: 630
  ident: bib6
  article-title: An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells
  publication-title: Science
– volume: 3
  start-page: 665
  year: 2021
  end-page: 681
  ident: bib52
  article-title: Mammary epithelial cells have lineage-rooted metabolic identities
  publication-title: Nat. Metab.
– volume: 25
  start-page: 850
  year: 2019
  end-page: 860
  ident: bib11
  article-title: The landscape of cancer cell line metabolism
  publication-title: Nat. Med.
– volume: 5
  start-page: 329
  year: 2019
  end-page: 332
  ident: bib32
  article-title: Cell Culture Medium Formulation and Its Implications in Cancer Metabolism
  publication-title: Trends Cancer
– volume: 22
  start-page: 343
  year: 2021
  ident: bib35
  article-title: Chronos: a cell population dynamics model of CRISPR experiments that improves inference of gene fitness effects
  publication-title: Genome Biol.
– volume: 12
  start-page: 22
  year: 2021
  ident: bib26
  article-title: Global computational alignment of tumor and cell line transcriptional profiles
  publication-title: Nat. Commun.
– volume: 618
  start-page: 151
  year: 2023
  end-page: 158
  ident: bib9
  article-title: Uridine-derived ribose fuels glucose-restricted pancreatic cancer
  publication-title: Nature
– volume: 2
  start-page: 401
  year: 2012
  end-page: 404
  ident: bib74
  article-title: The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
  publication-title: Cancer Discov.
– volume: 615
  start-page: 712
  year: 2023
  end-page: 719
  ident: bib56
  article-title: Spatial mapping of mitochondrial networks and bioenergetics in lung cancer
  publication-title: Nature
– volume: 77
  start-page: 3131
  year: 2017
  end-page: 3134
  ident: bib54
  article-title: Nature and Nurture: What Determines Tumor Metabolic Phenotypes?
  publication-title: Cancer Res.
– volume: 186
  start-page: 1670
  year: 2023
  end-page: 1688
  ident: bib1
  article-title: What is cancer metabolism?
  publication-title: Cell
– volume: 83
  start-page: 316
  year: 2023
  end-page: 331
  ident: bib75
  article-title: Loss of NF1 in Melanoma Confers Sensitivity to SYK Kinase Inhibition
  publication-title: Cancer Res.
– volume: 25
  start-page: 5537
  year: 2019
  end-page: 5547
  ident: bib44
  article-title: Genomic Correlates of Disease Progression and Treatment Response in Prospectively Characterized Gliomas
  publication-title: Clin. Cancer Res.
– volume: 483
  start-page: 603
  year: 2012
  end-page: 607
  ident: bib23
  article-title: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
  publication-title: Nature
– volume: 10
  start-page: 1797
  year: 2020
  end-page: 1807
  ident: bib4
  article-title: Targeting Metabolic Plasticity and Flexibility Dynamics for Cancer Therapy
  publication-title: Cancer Discov.
– volume: 29
  start-page: 25
  year: 2018
  end-page: 38
  ident: bib68
  article-title: The Cellosaurus, a Cell-Line Knowledge Resource
  publication-title: J. Biomol. Tech.
– volume: 52
  start-page: D1210
  year: 2024
  end-page: D1217
  ident: bib34
  article-title: COSMIC: a curated database of somatic variants and clinical data for cancer
  publication-title: Nucleic Acids Res.
– start-page: 472
  year: 1979
  end-page: 518
  ident: bib42
  article-title: Inhibitors of the ATP synthetase systems
  publication-title: Methods in Enzymology
– volume: 34
  year: 2021
  ident: bib5
  article-title: Single-cell resolved imaging reveals intra-tumor heterogeneity in glycolysis, transitions between metabolic states, and their regulatory mechanisms
  publication-title: Cell Rep.
– volume: 7
  start-page: 379
  year: 2022
  ident: bib19
  article-title: Organelle-targeted therapies: a comprehensive review on system design for enabling precision oncology
  publication-title: Signal Transduct. Targeted Ther.
– volume: 18
  year: 2022
  ident: bib16
  article-title: Heterogeneity of the cancer cell line metabolic landscape
  publication-title: Mol. Syst. Biol.
– volume: 41
  year: 2022
  ident: bib22
  article-title: Opa1 and Drp1 reciprocally regulate cristae morphology, ETC function, and NAD+ regeneration in KRas-mutant lung adenocarcinoma
  publication-title: Cell Rep.
– volume: 12
  start-page: 2037
  year: 2021
  ident: bib38
  article-title: Systems serology detects functionally distinct coronavirus antibody features in children and elderly
  publication-title: Nat. Commun.
– volume: 23
  start-page: 58
  year: 2018
  end-page: 67
  ident: bib59
  article-title: Mitochondrial Complex I Inhibitors Expose a Vulnerability for Selective Killing of Pten-Null Cells
  publication-title: Cell Rep.
– volume: 35
  year: 2021
  ident: bib63
  article-title: Inhibition of mitochondrial translation suppresses glioblastoma stem cell growth
  publication-title: Cell Rep.
– volume: 52
  start-page: 1208
  year: 2020
  end-page: 1218
  ident: bib31
  article-title: Pan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneity
  publication-title: Nat. Genet.
– volume: 6
  start-page: 743
  year: 2011
  end-page: 760
  ident: bib30
  article-title: Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst
  publication-title: Nat. Protoc.
– volume: 14
  start-page: 2692
  year: 2023
  ident: bib67
  article-title: Spatially resolved multi-omics highlights cell-specific metabolic remodeling and interactions in gastric cancer
  publication-title: Nat. Commun.
– volume: 12
  start-page: 7190
  year: 2021
  ident: bib17
  article-title: Metabolic drug survey highlights cancer cell dependencies and vulnerabilities
  publication-title: Nat. Commun.
– volume: 546
  start-page: 168
  year: 2017
  end-page: 172
  ident: bib8
  article-title: CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells
  publication-title: Nature
– volume: 146
  start-page: 209
  year: 2011
  end-page: 221
  ident: bib71
  article-title: Mosaic analysis with double markers reveals tumor cell of origin in glioma
  publication-title: Cell
– volume: 7
  start-page: 478
  year: 2017
  end-page: 493
  ident: bib7
  article-title: AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations
  publication-title: Cancer Discov.
– volume: 19
  start-page: 460
  year: 2023
  end-page: 476
  ident: bib51
  article-title: Metformin: update on mechanisms of action and repurposing potential
  publication-title: Nat. Rev. Endocrinol.
– volume: 44
  start-page: D457
  year: 2016
  end-page: D462
  ident: bib25
  article-title: KEGG as a reference resource for gene and protein annotation
  publication-title: Nucleic Acids Res.
– volume: 568
  start-page: 511
  year: 2019
  end-page: 516
  ident: bib36
  article-title: Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens
  publication-title: Nature
– volume: 2
  start-page: 141
  year: 2021
  end-page: 156
  ident: bib62
  article-title: Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilities
  publication-title: Nat. Can. (Ott.)
– volume: 12
  start-page: 109
  year: 2016
  end-page: 116
  ident: bib41
  article-title: Correlating chemical sensitivity and basal gene expression reveals mechanism of action
  publication-title: Nat. Chem. Biol.
– volume: 567
  start-page: 341
  year: 2019
  end-page: 346
  ident: bib45
  article-title: Gboxin is an oxidative phosphorylation inhibitor that targets glioblastoma
  publication-title: Nature
– volume: 17
  year: 2021
  ident: bib13
  article-title: The landscape of metabolic pathway dependencies in cancer cell lines
  publication-title: PLoS Comput. Biol.
– volume: 9
  start-page: 35
  year: 2021
  ident: bib18
  article-title: Robust metabolic transcriptional components in 34,494 patient-derived cancer-related samples and cell lines
  publication-title: Cancer Metabol.
– volume: 31
  start-page: 618
  year: 2021
  end-page: 620
  ident: bib33
  article-title: Oxidative phosphorylation system and cell culture media
  publication-title: Trends Cell Biol.
– volume: 155
  start-page: 160
  year: 2013
  end-page: 171
  ident: bib57
  article-title: Mitochondrial cristae shape determines respiratory chain supercomplexes assembly and respiratory efficiency
  publication-title: Cell
– volume: 9
  start-page: 42
  year: 2023
  ident: bib66
  article-title: Metabolomics and transcriptomics based multi-omics integration reveals radiation-induced altered pathway networking and underlying mechanism
  publication-title: NPJ Syst. Biol. Appl.
– volume: 37
  start-page: 38
  year: 2018
  end-page: 44
  ident: bib24
  article-title: Dimensionality reduction for visualizing single-cell data using UMAP
  publication-title: Nat. Biotechnol.
– volume: 10
  start-page: 3763
  year: 2019
  ident: bib29
  article-title: Metabolic landscape of the tumor microenvironment at single cell resolution
  publication-title: Nat. Commun.
– volume: 24
  start-page: 1036
  year: 2018
  end-page: 1046
  ident: bib46
  article-title: An inhibitor of oxidative phosphorylation exploits cancer vulnerability
  publication-title: Nat. Med.
– volume: 21
  start-page: 141
  year: 2022
  end-page: 162
  ident: bib2
  article-title: Targeting cancer metabolism in the era of precision oncology
  publication-title: Nat. Rev. Drug Discov.
– volume: 40
  start-page: 1488
  year: 2022
  end-page: 1502.e7
  ident: bib10
  article-title: Cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastoma
  publication-title: Cancer Cell
– volume: 569
  start-page: 503
  year: 2019
  end-page: 508
  ident: bib12
  article-title: Next-generation characterization of the Cancer Cell Line Encyclopedia
  publication-title: Nature
– volume: 5
  start-page: 1029
  year: 2023
  end-page: 1044
  ident: bib20
  article-title: A multimodal atlas of tumour metabolism reveals the architecture of gene-metabolite covariation
  publication-title: Nat. Metab.
– volume: 18
  year: 2022
  ident: bib15
  article-title: A functional analysis of 180 cancer cell lines reveals conserved intrinsic metabolic programs
  publication-title: Mol. Syst. Biol.
– volume: 17
  start-page: 37
  year: 2019
  ident: bib14
  article-title: Inferring cancer dependencies on metabolic genes from large-scale genetic screens
  publication-title: BMC Biol.
– volume: 117
  start-page: 13447
  year: 2020
  end-page: 13456
  ident: bib39
  article-title: TiPARP forms nuclear condensates to degrade HIF-1α and suppress tumorigenesis
  publication-title: Proc. Natl. Acad. Sci. USA
– volume: 129
  start-page: 897
  year: 2023
  end-page: 899
  ident: bib61
  article-title: Targeting mitochondrial oxidative phosphorylation: lessons, advantages, and opportunities
  publication-title: Br. J. Cancer
– volume: 22
  start-page: 343
  year: 2021
  ident: 10.1016/j.celrep.2024.114775_bib35
  article-title: Chronos: a cell population dynamics model of CRISPR experiments that improves inference of gene fitness effects
  publication-title: Genome Biol.
  doi: 10.1186/s13059-021-02540-7
– volume: 23
  start-page: 149
  year: 1994
  ident: 10.1016/j.celrep.2024.114775_bib73
  article-title: Exponentially weighted moving principal components analysis and projections to latent structures
  publication-title: Chemometr. Intell. Lab. Syst.
  doi: 10.1016/0169-7439(93)E0075-F
– volume: 12
  start-page: 109
  year: 2016
  ident: 10.1016/j.celrep.2024.114775_bib41
  article-title: Correlating chemical sensitivity and basal gene expression reveals mechanism of action
  publication-title: Nat. Chem. Biol.
  doi: 10.1038/nchembio.1986
– volume: 52
  start-page: D1210
  year: 2024
  ident: 10.1016/j.celrep.2024.114775_bib34
  article-title: COSMIC: a curated database of somatic variants and clinical data for cancer
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkad986
– volume: 10
  start-page: 1797
  year: 2020
  ident: 10.1016/j.celrep.2024.114775_bib4
  article-title: Targeting Metabolic Plasticity and Flexibility Dynamics for Cancer Therapy
  publication-title: Cancer Discov.
  doi: 10.1158/2159-8290.CD-20-0844
– volume: 29
  start-page: 25
  year: 2018
  ident: 10.1016/j.celrep.2024.114775_bib68
  article-title: The Cellosaurus, a Cell-Line Knowledge Resource
  publication-title: J. Biomol. Tech.
  doi: 10.7171/jbt.18-2902-002
– volume: 5
  start-page: 329
  year: 2019
  ident: 10.1016/j.celrep.2024.114775_bib32
  article-title: Cell Culture Medium Formulation and Its Implications in Cancer Metabolism
  publication-title: Trends Cancer
  doi: 10.1016/j.trecan.2019.05.004
– volume: 3
  start-page: 665
  year: 2021
  ident: 10.1016/j.celrep.2024.114775_bib52
  article-title: Mammary epithelial cells have lineage-rooted metabolic identities
  publication-title: Nat. Metab.
  doi: 10.1038/s42255-021-00388-6
– volume: 83
  start-page: 316
  year: 2023
  ident: 10.1016/j.celrep.2024.114775_bib75
  article-title: Loss of NF1 in Melanoma Confers Sensitivity to SYK Kinase Inhibition
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-22-0883
– volume: 44
  start-page: D457
  year: 2016
  ident: 10.1016/j.celrep.2024.114775_bib25
  article-title: KEGG as a reference resource for gene and protein annotation
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkv1070
– volume: 34
  year: 2021
  ident: 10.1016/j.celrep.2024.114775_bib5
  article-title: Single-cell resolved imaging reveals intra-tumor heterogeneity in glycolysis, transitions between metabolic states, and their regulatory mechanisms
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2021.108750
– volume: 35
  year: 2021
  ident: 10.1016/j.celrep.2024.114775_bib63
  article-title: Inhibition of mitochondrial translation suppresses glioblastoma stem cell growth
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2021.109024
– volume: 10
  year: 2015
  ident: 10.1016/j.celrep.2024.114775_bib47
  article-title: Metformin inhibits growth of human glioblastoma cells and enhances therapeutic response
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0123721
– volume: 155
  start-page: 160
  year: 2013
  ident: 10.1016/j.celrep.2024.114775_bib57
  article-title: Mitochondrial cristae shape determines respiratory chain supercomplexes assembly and respiratory efficiency
  publication-title: Cell
  doi: 10.1016/j.cell.2013.08.032
– volume: 17
  start-page: 37
  year: 2019
  ident: 10.1016/j.celrep.2024.114775_bib14
  article-title: Inferring cancer dependencies on metabolic genes from large-scale genetic screens
  publication-title: BMC Biol.
  doi: 10.1186/s12915-019-0654-4
– volume: 567
  start-page: 341
  year: 2019
  ident: 10.1016/j.celrep.2024.114775_bib45
  article-title: Gboxin is an oxidative phosphorylation inhibitor that targets glioblastoma
  publication-title: Nature
  doi: 10.1038/s41586-019-0993-x
– volume: 38
  start-page: 675
  year: 2020
  ident: 10.1016/j.celrep.2024.114775_bib28
  article-title: Visualizing and interpreting cancer genomics data via the Xena platform
  publication-title: Nat. Biotechnol.
  doi: 10.1038/s41587-020-0546-8
– volume: 41
  year: 2022
  ident: 10.1016/j.celrep.2024.114775_bib22
  article-title: Opa1 and Drp1 reciprocally regulate cristae morphology, ETC function, and NAD+ regeneration in KRas-mutant lung adenocarcinoma
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2022.111818
– volume: 25
  start-page: 5537
  year: 2019
  ident: 10.1016/j.celrep.2024.114775_bib44
  article-title: Genomic Correlates of Disease Progression and Treatment Response in Prospectively Characterized Gliomas
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-19-0032
– volume: 2
  start-page: 401
  year: 2012
  ident: 10.1016/j.celrep.2024.114775_bib74
  article-title: The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
  publication-title: Cancer Discov.
  doi: 10.1158/2159-8290.CD-12-0095
– volume: 2
  start-page: 141
  year: 2021
  ident: 10.1016/j.celrep.2024.114775_bib62
  article-title: Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilities
  publication-title: Nat. Can. (Ott.)
  doi: 10.1038/s43018-020-00159-4
– volume: 29
  start-page: 115
  year: 2023
  ident: 10.1016/j.celrep.2024.114775_bib60
  article-title: Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials
  publication-title: Nat. Med.
  doi: 10.1038/s41591-022-02103-8
– volume: 25
  start-page: 850
  year: 2019
  ident: 10.1016/j.celrep.2024.114775_bib11
  article-title: The landscape of cancer cell line metabolism
  publication-title: Nat. Med.
  doi: 10.1038/s41591-019-0404-8
– volume: 12
  start-page: 5961
  year: 2021
  ident: 10.1016/j.celrep.2024.114775_bib40
  article-title: Cancer gene mutation frequencies for the U.S. population
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-021-26213-y
– volume: 568
  start-page: 511
  year: 2019
  ident: 10.1016/j.celrep.2024.114775_bib36
  article-title: Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens
  publication-title: Nature
  doi: 10.1038/s41586-019-1103-9
– volume: 615
  start-page: 712
  year: 2023
  ident: 10.1016/j.celrep.2024.114775_bib56
  article-title: Spatial mapping of mitochondrial networks and bioenergetics in lung cancer
  publication-title: Nature
  doi: 10.1038/s41586-023-05793-3
– volume: 12
  start-page: 7190
  year: 2021
  ident: 10.1016/j.celrep.2024.114775_bib17
  article-title: Metabolic drug survey highlights cancer cell dependencies and vulnerabilities
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-021-27329-x
– volume: 9
  start-page: 1677
  year: 2018
  ident: 10.1016/j.celrep.2024.114775_bib58
  article-title: Dysregulation of mitochondrial dynamics proteins are a targetable feature of human tumors
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-018-04033-x
– volume: 12
  start-page: 2037
  year: 2021
  ident: 10.1016/j.celrep.2024.114775_bib38
  article-title: Systems serology detects functionally distinct coronavirus antibody features in children and elderly
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-021-22236-7
– year: 2023
  ident: 10.1016/j.celrep.2024.114775_bib21
  article-title: Data-Driven Screening to Infer Metabolic Modulators of the Cancer Epigenome
  publication-title: bioRxiv
– volume: 22
  start-page: 433
  year: 2021
  ident: 10.1016/j.celrep.2024.114775_bib70
  article-title: CellProfiler 4: improvements in speed, utility and usability
  publication-title: BMC Bioinf.
  doi: 10.1186/s12859-021-04344-9
– volume: 1870
  start-page: 76
  year: 2018
  ident: 10.1016/j.celrep.2024.114775_bib3
  article-title: Targeting cancer’s metabolic co-dependencies: A landscape shaped by genotype and tissue context
  publication-title: Biochim. Biophys. Acta Rev. Canc
  doi: 10.1016/j.bbcan.2018.05.002
– volume: 31
  start-page: 618
  year: 2021
  ident: 10.1016/j.celrep.2024.114775_bib33
  article-title: Oxidative phosphorylation system and cell culture media
  publication-title: Trends Cell Biol.
  doi: 10.1016/j.tcb.2021.05.003
– volume: 340
  start-page: 626
  year: 2013
  ident: 10.1016/j.celrep.2024.114775_bib6
  article-title: An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells
  publication-title: Science
  doi: 10.1126/science.1236062
– volume: 7
  start-page: 478
  year: 2017
  ident: 10.1016/j.celrep.2024.114775_bib7
  article-title: AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations
  publication-title: Cancer Discov.
  doi: 10.1158/2159-8290.CD-16-1034
– volume: 19
  start-page: 460
  year: 2023
  ident: 10.1016/j.celrep.2024.114775_bib51
  article-title: Metformin: update on mechanisms of action and repurposing potential
  publication-title: Nat. Rev. Endocrinol.
  doi: 10.1038/s41574-023-00833-4
– volume: 20
  start-page: 57
  year: 2020
  ident: 10.1016/j.celrep.2024.114775_bib64
  article-title: Altered cellular metabolism in gliomas - an emerging landscape of actionable co-dependency targets
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/s41568-019-0226-5
– volume: 12
  start-page: 22
  year: 2021
  ident: 10.1016/j.celrep.2024.114775_bib26
  article-title: Global computational alignment of tumor and cell line transcriptional profiles
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-020-20294-x
– volume: 77
  start-page: 3131
  year: 2017
  ident: 10.1016/j.celrep.2024.114775_bib54
  article-title: Nature and Nurture: What Determines Tumor Metabolic Phenotypes?
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-17-0165
– volume: 24
  start-page: 1036
  year: 2018
  ident: 10.1016/j.celrep.2024.114775_bib46
  article-title: An inhibitor of oxidative phosphorylation exploits cancer vulnerability
  publication-title: Nat. Med.
  doi: 10.1038/s41591-018-0052-4
– volume: 18
  start-page: 1413
  year: 2016
  ident: 10.1016/j.celrep.2024.114775_bib50
  article-title: Culture conditions tailored to the cell of origin are critical for maintaining native properties and tumorigenicity of glioma cells
  publication-title: Neuro Oncol.
  doi: 10.1093/neuonc/now062
– volume: 353
  start-page: 1161
  year: 2016
  ident: 10.1016/j.celrep.2024.114775_bib55
  article-title: Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers
  publication-title: Science
  doi: 10.1126/science.aaf5171
– volume: 483
  start-page: 603
  year: 2012
  ident: 10.1016/j.celrep.2024.114775_bib23
  article-title: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
  publication-title: Nature
  doi: 10.1038/nature11003
– volume: 5
  start-page: 1029
  year: 2023
  ident: 10.1016/j.celrep.2024.114775_bib20
  article-title: A multimodal atlas of tumour metabolism reveals the architecture of gene-metabolite covariation
  publication-title: Nat. Metab.
  doi: 10.1038/s42255-023-00817-8
– volume: 44
  start-page: W90
  year: 2016
  ident: 10.1016/j.celrep.2024.114775_bib69
  article-title: Enrichr: a comprehensive gene set enrichment analysis web server 2016 update
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkw377
– year: 2022
  ident: 10.1016/j.celrep.2024.114775_bib49
  article-title: Harmonized single-cell landscape, intercellular crosstalk and tumor architecture of glioblastoma
  publication-title: bioRxiv
– volume: 32
  start-page: 148
  year: 2002
  ident: 10.1016/j.celrep.2024.114775_bib72
  article-title: Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene
  publication-title: Genesis
  doi: 10.1002/gene.10036
– volume: 117
  start-page: 13447
  year: 2020
  ident: 10.1016/j.celrep.2024.114775_bib39
  article-title: TiPARP forms nuclear condensates to degrade HIF-1α and suppress tumorigenesis
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.1921815117
– volume: 18
  year: 2022
  ident: 10.1016/j.celrep.2024.114775_bib15
  article-title: A functional analysis of 180 cancer cell lines reveals conserved intrinsic metabolic programs
  publication-title: Mol. Syst. Biol.
  doi: 10.15252/msb.202211033
– volume: 6
  start-page: 743
  year: 2011
  ident: 10.1016/j.celrep.2024.114775_bib30
  article-title: Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst
  publication-title: Nat. Protoc.
  doi: 10.1038/nprot.2011.319
– volume: 21
  start-page: 141
  year: 2022
  ident: 10.1016/j.celrep.2024.114775_bib2
  article-title: Targeting cancer metabolism in the era of precision oncology
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/s41573-021-00339-6
– volume: 9
  start-page: 42
  year: 2023
  ident: 10.1016/j.celrep.2024.114775_bib66
  article-title: Metabolomics and transcriptomics based multi-omics integration reveals radiation-induced altered pathway networking and underlying mechanism
  publication-title: NPJ Syst. Biol. Appl.
  doi: 10.1038/s41540-023-00305-5
– volume: 569
  start-page: 503
  year: 2019
  ident: 10.1016/j.celrep.2024.114775_bib12
  article-title: Next-generation characterization of the Cancer Cell Line Encyclopedia
  publication-title: Nature
  doi: 10.1038/s41586-019-1186-3
– volume: 40
  start-page: 1488
  year: 2022
  ident: 10.1016/j.celrep.2024.114775_bib10
  article-title: Cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastoma
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2022.10.009
– volume: 10
  start-page: 3763
  year: 2019
  ident: 10.1016/j.celrep.2024.114775_bib29
  article-title: Metabolic landscape of the tumor microenvironment at single cell resolution
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-019-11738-0
– volume: 14
  start-page: 2692
  year: 2023
  ident: 10.1016/j.celrep.2024.114775_bib67
  article-title: Spatially resolved multi-omics highlights cell-specific metabolic remodeling and interactions in gastric cancer
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-023-38360-5
– volume: 4
  start-page: 418
  year: 2008
  ident: 10.1016/j.celrep.2024.114775_bib43
  article-title: Synthesis enables identification of the cellular target of leucascandrolide A and neopeltolide
  publication-title: Nat. Chem. Biol.
  doi: 10.1038/nchembio.94
– volume: 17
  year: 2021
  ident: 10.1016/j.celrep.2024.114775_bib13
  article-title: The landscape of metabolic pathway dependencies in cancer cell lines
  publication-title: PLoS Comput. Biol.
  doi: 10.1371/journal.pcbi.1008942
– volume: 9
  start-page: 35
  year: 2021
  ident: 10.1016/j.celrep.2024.114775_bib18
  article-title: Robust metabolic transcriptional components in 34,494 patient-derived cancer-related samples and cell lines
  publication-title: Cancer Metabol.
  doi: 10.1186/s40170-021-00272-7
– volume: 45
  start-page: 1113
  year: 2013
  ident: 10.1016/j.celrep.2024.114775_bib27
  article-title: The Cancer Genome Atlas Pan-Cancer analysis project
  publication-title: Nat. Genet.
  doi: 10.1038/ng.2764
– volume: 576
  start-page: 112
  year: 2019
  ident: 10.1016/j.celrep.2024.114775_bib48
  article-title: Longitudinal molecular trajectories of diffuse glioma in adults
  publication-title: Nature
  doi: 10.1038/s41586-019-1775-1
– volume: 186
  start-page: 1670
  year: 2023
  ident: 10.1016/j.celrep.2024.114775_bib1
  article-title: What is cancer metabolism?
  publication-title: Cell
  doi: 10.1016/j.cell.2023.01.038
– volume: 618
  start-page: 151
  year: 2023
  ident: 10.1016/j.celrep.2024.114775_bib9
  article-title: Uridine-derived ribose fuels glucose-restricted pancreatic cancer
  publication-title: Nature
  doi: 10.1038/s41586-023-06073-w
– volume: 7
  start-page: 379
  year: 2022
  ident: 10.1016/j.celrep.2024.114775_bib19
  article-title: Organelle-targeted therapies: a comprehensive review on system design for enabling precision oncology
  publication-title: Signal Transduct. Targeted Ther.
  doi: 10.1038/s41392-022-01243-0
– volume: 546
  start-page: 168
  year: 2017
  ident: 10.1016/j.celrep.2024.114775_bib8
  article-title: CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells
  publication-title: Nature
  doi: 10.1038/nature22359
– volume: 146
  start-page: 209
  year: 2011
  ident: 10.1016/j.celrep.2024.114775_bib71
  article-title: Mosaic analysis with double markers reveals tumor cell of origin in glioma
  publication-title: Cell
  doi: 10.1016/j.cell.2011.06.014
– start-page: 472
  year: 1979
  ident: 10.1016/j.celrep.2024.114775_bib42
  article-title: Inhibitors of the ATP synthetase systems
  doi: 10.1016/0076-6879(79)55061-7
– volume: 37
  start-page: 38
  year: 2018
  ident: 10.1016/j.celrep.2024.114775_bib24
  article-title: Dimensionality reduction for visualizing single-cell data using UMAP
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt.4314
– volume: 24
  start-page: 221
  year: 2018
  ident: 10.1016/j.celrep.2024.114775_bib37
  article-title: A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2018.07.009
– volume: 52
  start-page: 1208
  year: 2020
  ident: 10.1016/j.celrep.2024.114775_bib31
  article-title: Pan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneity
  publication-title: Nat. Genet.
  doi: 10.1038/s41588-020-00726-6
– volume: 18
  year: 2022
  ident: 10.1016/j.celrep.2024.114775_bib16
  article-title: Heterogeneity of the cancer cell line metabolic landscape
  publication-title: Mol. Syst. Biol.
  doi: 10.15252/msb.202211006
– volume: 129
  start-page: 897
  year: 2023
  ident: 10.1016/j.celrep.2024.114775_bib61
  article-title: Targeting mitochondrial oxidative phosphorylation: lessons, advantages, and opportunities
  publication-title: Br. J. Cancer
  doi: 10.1038/s41416-023-02394-9
– volume: 14
  start-page: 8260
  year: 2023
  ident: 10.1016/j.celrep.2024.114775_bib65
  article-title: Single-cell spatial metabolomics with cell-type specific protein profiling for tissue systems biology
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-023-43917-5
– volume: 23
  start-page: 58
  year: 2018
  ident: 10.1016/j.celrep.2024.114775_bib59
  article-title: Mitochondrial Complex I Inhibitors Expose a Vulnerability for Selective Killing of Pten-Null Cells
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2018.03.032
– volume: 11
  start-page: 4830
  year: 2020
  ident: 10.1016/j.celrep.2024.114775_bib53
  article-title: Raman-guided subcellular pharmaco-metabolomics for metastatic melanoma cells
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-020-18376-x
– reference: 38076921 - bioRxiv. 2024 Jul 10:2023.11.28.569098. doi: 10.1101/2023.11.28.569098
SSID ssj0000601194
Score 2.4186685
Snippet Targeting the distinct metabolic needs of tumor cells has recently emerged as a promising strategy for cancer therapy. The heterogeneous, context-dependent...
SourceID doaj
unpaywall
pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 114775
SubjectTerms Animals
cancer metabolism
cancer therapies
Cell Line, Tumor
CP: Cancer
CP: Metabolism
glioma
Humans
metabolic state vulnerabilities
Mitochondria - metabolism
mitochondrial electron transport chain
Multivariate Analysis
multivariate modeling
Neoplasms - genetics
Neoplasms - metabolism
Neoplasms - pathology
Oxidative Phosphorylation
PTEN
Synthetic Lethal Mutations
synthetic lethality
SummonAdditionalLinks – databaseName: ScienceDirect Free & Delayed Access Titles
  dbid: IXB
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqShVcEG9SKDIS17B27F3HR1q1qpDgApX2Zk0chwaF7GofRXvknzPjJEujHoo45rGJH59nvsnOfGbsvQGpgy5CWiF1S7U2Ji2Eh1SoIEEpUypDtcOfv8wur_Sn-XR-wM6GWhhKq-xtf2fTo7Xuz0z60Zws63ryNcPYBb2TQZ9EdTCkCaq0iUV889P9dxbSG5FxP0S6P6UfDBV0Mc3Lh2YVSLgy06Sbayjh8JaHikL-I0d1l4jezad8sG2XsPsFTXPLWV08Zo96lsk_dh15wg5C-5QddftO7p6x37Hs9gbDZGSaHHpdEr6o-M-wQVQ0teex0ojfbBuSpY4ZtBhTc4ht5mXM5gjcE2ZWnPLd0civOelBIZ75etcisYyfyZsdR2hcY2vgLxLWz9nVxfm3s8u034sh9drYDZpqiV4Mw0WlfAYSphZXP7KvYJWHUFbGl6EAafzMqtzLinTTykLkGP0JVaFZfcEO20UbXjFuAXzAwLK0UGprhK1EVlnhZ8jlCgxYEpYO4--WneSGG3LRfrhuvhzNl-vmK2GnNEn7e0kwO55YrL67HjHOl3YawpQUx0qdSw05KOsLZXISEBImYWaYYjfCHz6qvuf17wZEOFya9H8LtGGxXTtkzsYgo52phL3sELJvpLJoaHWOV_IRdka9GF9p6-so_40cXuIzRcI-7GH2TwN1_N99fM0e0hH57Cx7ww43q204QTK2Kd7G1fYH3Yg0WA
  priority: 102
  providerName: Elsevier
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELVKEYIL4pvwJSNxTZXEzjo-IASIqkIqJ1bqzZrYDl0UsiXZLeTIP2fGSbZEBcGB62bjeGfeeN5kx8-MvVCQSi9LH1dI3WIplYrLxEKcCJ-CEMoJRXuHjz8sjpby_Ul-ssemM1tHA3a_Le3oPKllWx98_9q_woB_edGrZX3delKfzCSJ3yqVX2FXMTdlhPPjkfAPazNpnMlpD90fbp7lqCDlP0tVl6no5Y7K69vmDPpvUNe_pKvDW-zmyDP56wEYt9meb-6wa8PJk_1d9iNsvD3HQhm5JodRmYSvK_7FbxAX9crysNeIn29rEqYOPbRYVXMIc-Yu9HN4bgk1LaeOd1zmO06KUGhZ3vUNUsvworzuOYLjFGcDF1jo7rHl4buPb4_i8TSG2EqlN7hYp5jHsGAUwmaQQq4x_pF_eS0seFcp63wJqbILLQqbVqSc5sqkwPovERUurPfZfrNu_EPGNYD1WFo6DU5qlegqySqd2AWyuRJLlojFk_3N2SC6YaZutM9m8Jchf5nBXxF7Q07afZcks8MH6_aTGSPQWKdz73PSHHOySCUUILQthSpIQihREVOTi83IPgZWgUOt_vL45xMiDAYn_eMCjV9vO4PcWSnktAsRsQcDQnaTFBqXWlnglWKGndmvmF9pVqdBABxZfIpjJhE72MHsnwz16H8Y6jG7QUNSAs-yJ2x_0279U2Rmm_JZCLafVqw6Vg
  priority: 102
  providerName: Scholars Portal
Title Multivariate analysis of metabolic state vulnerabilities across diverse cancer contexts reveals synthetically lethal associations
URI https://dx.doi.org/10.1016/j.celrep.2024.114775
https://www.ncbi.nlm.nih.gov/pubmed/39305483
https://www.proquest.com/docview/3107785163
https://pubmed.ncbi.nlm.nih.gov/PMC11511630
https://doi.org/10.1016/j.celrep.2024.114775
https://doaj.org/article/cd95ee50557d4814a8a39cb378017007
UnpaywallVersion publishedVersion
Volume 43
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 2211-1247
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000601194
  issn: 2211-1247
  databaseCode: KQ8
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 2211-1247
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000601194
  issn: 2211-1247
  databaseCode: KQ8
  dateStart: 20120126
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2211-1247
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000601194
  issn: 2211-1247
  databaseCode: DOA
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVESC
  databaseName: ScienceDirect Free & Delayed Access Titles
  customDbUrl:
  eissn: 2211-1247
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000601194
  issn: 2211-1247
  databaseCode: IXB
  dateStart: 20120126
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 2211-1247
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000601194
  issn: 2211-1247
  databaseCode: DIK
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: Geneva Foundation for Medical Education and Research Open Access Journals
  customDbUrl:
  eissn: 2211-1247
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000601194
  issn: 2211-1247
  databaseCode: GX1
  dateStart: 0
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVLSH
  databaseName: Elsevier Journals
  customDbUrl:
  mediaType: online
  eissn: 2211-1247
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000601194
  issn: 2211-1247
  databaseCode: AKRWK
  dateStart: 20120126
  isFulltext: true
  providerName: Library Specific Holdings
– providerCode: PRVFZP
  databaseName: Scholars Portal Journals: Open Access
  customDbUrl:
  eissn: 2211-1247
  dateEnd: 20250930
  omitProxy: true
  ssIdentifier: ssj0000601194
  issn: 2211-1247
  databaseCode: M48
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: http://journals.scholarsportal.info
  providerName: Scholars Portal
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELbQSgguiDfhJSNxDSSxW8dHFrFakJYTK_VmTeyJtiikqz521SP_nBk7Ka32sBy45NBUruP5PPNNOvNZiPcGSo26wbwl6pZrbUzeFB7yQmEJSpmgDPcOn32fnp7rb7PJbO-oL64JS_LAaeE--mAniBOWigq6LjXUoKxvlKlZ-SX1kVMY20umkg9mLTM99srFgi6P3RJZorLSrJBruLRwLxZFyf6DkHSTct6snLy36S9hew1dtxeWTh6KBwOflJ_SczwSd7B_LO6mEya3T8Tv2GB7RQkxcUoJgwKJXLTyF67J_t3cy9hTJK82HQtQx1pZyp4lxDnLEOs2UHpGx1JyZTu585Vk5SdCrlxte6KQ8YV4t5UEgguaDfy1-eqpOD_58uPzaT6cupB7beyanHJJ8YoSQ6V8BSVMLO1z4llolQcMrfEBGyiNn1pV-7JlhbTQFDXleYVqyYE-E0f9oscXQloAj5RCBgtBW1PYtqhaW_gpsbaGUpNM5OP6u8skruHGqrOfLtnLsb1cslcmjtlIu--yNHb8gADjBsC42wCTCTOa2A0sI7EHGmp-y8-_GxHhaBPyPyvQ42KzcsSRjSHuOlWZeJ4QspuksuRSdU136gPsHDzF4Z1-fhGFvomtlzRmkYkPO5j900K9_B8L9Urc5yE5UFfVa3G0Xm7wDTGwdfM2bja6fp0d0_VM138ATWQyYg
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VItReEG-Wp5G4hnVi7zo-0opqC20vtNLeLMdx2qCQXe2j1R7558w4ydKoBxDXeJO1PZ9nvknGnwE-KhtLLzMfFUjdIimVijLubMSFj60QKheK9g6fno0nF_LrdDTdgcNuLwyVVba-v_HpwVu3V4btbA7nZTn8nmDugtFJYUyifTDyHtxHNsCprut4erB90UKCI3E4EJFuiOiObgtdqPNyvlp4Uq5MJAnnKqo4vBWigpJ_L1LdZaJ3Cyr31vXcbm5sVd2KVkeP4GFLM9nnZiSPYcfXT-BBc_Dk5in8CvturzFPRqrJbCtMwmYF--lXCIuqdCxsNWLX64p0qUMJLSbVzIY-szyUc3jmCDQLRgXv6OWXjAShENBsuamRWYb35NWGITausDf2DxSWz-Di6Mv54SRqD2OInFR6hb46xjCG-aIQLrGxHWlc_ki_vBbO-rxQLveZjZUba5G6uCDhtDzjKaZ_XBToV5_Dbj2r_Utg2lrnMbPMtc2lVlwXPCk0d2M0X4YZywCibv7NvNHcMF0x2g_T2MuQvUxjrwEckJG2vyXF7HBhtrg0LWSMy_XI-xFJjuUyjaVNrdAuEyolBSGuBqA6E5seAPFR5V_-_kOHCINrkz642NrP1kuD1FkppLRjMYAXDUK2nRQaPa1MsSXtYac3in5LXV4F_W8k8TE-kw_g0xZm_zRRr_57jO9hb3J-emJOjs--vYZ9aqEAniRvYHe1WPu3yMxW2buw8n4DVyI3eQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Multivariate+analysis+of+metabolic+state+vulnerabilities+across+diverse+cancer+contexts+reveals+synthetically+lethal+associations&rft.jtitle=Cell+reports+%28Cambridge%29&rft.au=Cara+Abecunas&rft.au=Audrey+D.+Kidd&rft.au=Ying+Jiang&rft.au=Hui+Zong&rft.date=2024-10-22&rft.pub=Elsevier&rft.eissn=2211-1247&rft.volume=43&rft.issue=10&rft.spage=114775&rft_id=info:doi/10.1016%2Fj.celrep.2024.114775&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_cd95ee50557d4814a8a39cb378017007
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2211-1247&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2211-1247&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2211-1247&client=summon